Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
IEEE Transactions on Neural Networks
|
January 1, 1993
Symmetries and discriminability in feedforward network architectures
J Shawe-Taylor
Biochemical and Biophysical Research Communications
|
September 1, 2009
Characterization of a novel focal adhesion kinase inhibitor in human platelets
Matthew L Jones, Amelia J Shawe-Taylor, Christopher M Williams, et al.
Neural Computation
|
July 7, 2001
Estimating the support of a high-dimensional distribution
B Schölkopf, J C Platt, J Shawe-Taylor, et al.
Optics Letters
|
October 30, 2009
Sigmoid neural transfer function realized by percolation
D Pignon, P J Parmiter, J K Slack, et al.
BMJ Neurology Open
|
December 22, 2025
Immunogenicity of three-dose COVID-19 vaccines in people living with multiple sclerosis
Marianne J Shawe-Taylor, David Greenwood, Anna He, et al.
European Journal of Neurology
|
April 3, 2024
Real-world persistence of multiple sclerosis disease-modifying therapies
Emma C Tallantyre, Ruth Dobson, Joseph L J Froud, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
IEEE Transactions on Neural Networks
|
January 1, 1993
Symmetries and discriminability in feedforward network architectures
J Shawe-Taylor
Biochemical and Biophysical Research Communications
|
September 1, 2009
Characterization of a novel focal adhesion kinase inhibitor in human platelets
Matthew L Jones, Amelia J Shawe-Taylor, Christopher M Williams, et al.
Neural Computation
|
July 7, 2001
Estimating the support of a high-dimensional distribution
B Schölkopf, J C Platt, J Shawe-Taylor, et al.
Optics Letters
|
October 30, 2009
Sigmoid neural transfer function realized by percolation
D Pignon, P J Parmiter, J K Slack, et al.
BMJ Neurology Open
|
December 22, 2025
Immunogenicity of three-dose COVID-19 vaccines in people living with multiple sclerosis
Marianne J Shawe-Taylor, David Greenwood, Anna He, et al.
European Journal of Neurology
|
April 3, 2024
Real-world persistence of multiple sclerosis disease-modifying therapies
Emma C Tallantyre, Ruth Dobson, Joseph L J Froud, et al.
Page
of 1